• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先兆亨廷顿病患者的大脑小动脉血容量升高。

Elevated arteriolar cerebral blood volume in prodromal Huntington's disease.

机构信息

The Russell H. Morgan Department of Radiology and Radiological Science, Division of Magnetic Resonance Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.

出版信息

Mov Disord. 2014 Mar;29(3):396-401. doi: 10.1002/mds.25591. Epub 2013 Jul 11.

DOI:10.1002/mds.25591
PMID:23847161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3834086/
Abstract

BACKGROUND

Neurovascular alterations have been implicated in the pathophysiology of Huntington's disease (HD). Because arterioles are most responsive to metabolic alterations, arteriolar cerebral blood volume (CBVa) is an important indicator of cerebrovascular regulation. The objective of this pilot study was to investigate potential neurovascular (CBVa ) abnormality in prodromal-HD patients and compare it with the widely used imaging marker: brain atrophy.

METHODS

CBVa and brain volumes were measured with ultra-high-field (7.0-Telsa) magnetic resonance imaging in seven prodromal-HD patients and nine age-matched controls.

RESULTS

Cortical CBVa was elevated significantly in prodromal-HD patients compared with controls (relative difference, 38.5%; effect size, 1.48). Significant correlations were found between CBVa in the frontal cortex and genetic measures. By contrast, no significant brain atrophy was detected in the prodromal-HD patients.

CONCLUSIONS

CBVa may be abnormal in prodromal-HD, even before substantial brain atrophy occurs. Further investigation with a larger cohort and longitudinal follow-up is merited to determine whether CBVa could be used as a potential biomarker for clinical trials.

摘要

背景

神经血管改变与亨廷顿病(HD)的病理生理学有关。由于小动脉对代谢改变最敏感,因此小动脉脑血容量(CBVa)是脑血管调节的重要指标。本初步研究的目的是研究前驱期 HD 患者潜在的神经血管(CBVa)异常,并将其与广泛使用的成像标志物:脑萎缩进行比较。

方法

使用超高场(7.0-Telsa)磁共振成像在 7 名前驱期 HD 患者和 9 名年龄匹配的对照者中测量 CBVa 和脑容量。

结果

与对照组相比,前驱期 HD 患者的皮质 CBVa 明显升高(相对差异,38.5%;效应大小,1.48)。在前额皮质的 CBVa 与遗传测量之间发现了显著的相关性。相比之下,前驱期 HD 患者没有发现明显的脑萎缩。

结论

即使在发生大量脑萎缩之前,前驱期 HD 患者的 CBVa 也可能异常。值得进一步研究更大的队列和纵向随访,以确定 CBVa 是否可用作临床试验的潜在生物标志物。

相似文献

1
Elevated arteriolar cerebral blood volume in prodromal Huntington's disease.先兆亨廷顿病患者的大脑小动脉血容量升高。
Mov Disord. 2014 Mar;29(3):396-401. doi: 10.1002/mds.25591. Epub 2013 Jul 11.
2
Abnormal Grey Matter Arteriolar Cerebral Blood Volume in Schizophrenia Measured With 3D Inflow-Based Vascular-Space-Occupancy MRI at 7T.使用7T基于三维流入的血管空间占据磁共振成像测量精神分裂症患者异常灰质小动脉脑血容量
Schizophr Bull. 2017 May 1;43(3):620-632. doi: 10.1093/schbul/sbw109.
3
Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.遗传负荷决定了亨廷顿病前症状期手部皮质纹状体通路的萎缩。
Hum Brain Mapp. 2018 Oct;39(10):3871-3883. doi: 10.1002/hbm.24217. Epub 2018 May 24.
4
Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease.先兆亨廷顿病患者皮质纹状体功能连接受损。
Neurosci Lett. 2012 Apr 18;514(2):204-9. doi: 10.1016/j.neulet.2012.02.095. Epub 2012 Mar 7.
5
Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.多模态影像生物标志物在未显症和早期亨廷顿病中的应用:IMAGE-HD 研究 30 个月数据。
Br J Psychiatry. 2016 Jun;208(6):571-8. doi: 10.1192/bjp.bp.114.156588. Epub 2015 Dec 17.
6
Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study.亨廷顿病患者皮质下脑结构的淡漠和萎缩:一项为期两年的随访研究。
Neuroimage Clin. 2018 Mar 27;19:66-70. doi: 10.1016/j.nicl.2018.03.033. eCollection 2018.
7
Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials.基于图谱的 MRI 体计量学的亨廷顿病联合脑萎缩评分:临床试验的样本量计算。
Parkinsonism Relat Disord. 2019 Jun;63:179-184. doi: 10.1016/j.parkreldis.2019.02.004. Epub 2019 Feb 5.
8
Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation.使用自动化分割技术,在亨廷顿病前驱期可在一年以上时间检测到基底节萎缩。
Mov Disord. 2011 Dec;26(14):2544-51. doi: 10.1002/mds.23912. Epub 2011 Sep 19.
9
Longitudinal change in regional brain volumes in prodromal Huntington disease.前驱期亨廷顿病患者脑区容积的纵向变化。
J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):405-10. doi: 10.1136/jnnp.2010.208264. Epub 2010 Sep 30.
10
Corpus callosal atrophy in premanifest and early Huntington's disease.临床前期和早期亨廷顿舞蹈病患者的胼胝体萎缩
J Huntingtons Dis. 2013;2(4):517-26. doi: 10.3233/JHD-130077.

引用本文的文献

1
From Brain to Blood: Uncovering Potential Therapeutical Targets and Biomarkers for Huntington's Disease Using an Integrative RNA-Seq Analytical Platform (BDASeq).从大脑到血液:使用综合RNA测序分析平台(BDASeq)揭示亨廷顿舞蹈症的潜在治疗靶点和生物标志物
Cells. 2025 Jun 25;14(13):976. doi: 10.3390/cells14130976.
2
Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington's disease.亨廷顿病 zQ175DN 小鼠模型中脑灌注和血管反应性的纵向变化。
J Biomed Sci. 2024 Apr 16;31(1):37. doi: 10.1186/s12929-024-01028-3.
3
The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease.

本文引用的文献

1
R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures.R6/2 亨廷顿舞蹈病小鼠出现早期和进行性的异常脑代谢和癫痫发作。
J Neurosci. 2012 May 9;32(19):6456-67. doi: 10.1523/JNEUROSCI.0388-12.2012.
2
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.TRACK-HD 研究中前驱期和早期亨廷顿病临床试验的潜在终点:24 个月观察数据的分析。
Lancet Neurol. 2012 Jan;11(1):42-53. doi: 10.1016/S1474-4422(11)70263-0. Epub 2011 Dec 2.
3
Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease.
临床前磁共振成像和光谱学对亨廷顿舞蹈病的贡献。
Front Aging Neurosci. 2024 Feb 13;16:1306312. doi: 10.3389/fnagi.2024.1306312. eCollection 2024.
4
On the optimization of 3D inflow-based vascular-space-occupancy (iVASO) MRI for the quantification of arterial cerebral blood volume (CBVa).基于三维流入的血管空间占据(iVASO)磁共振成像(MRI)用于定量脑动脉血容量(CBVa)的优化研究
Magn Reson Med. 2024 May;91(5):1893-1907. doi: 10.1002/mrm.29971. Epub 2023 Dec 19.
5
An altered extracellular matrix-integrin interface contributes to Huntington's disease-associated CNS dysfunction in glial and vascular cells.异常的细胞外基质-整合素界面导致亨廷顿病相关的神经胶质细胞和血管细胞的中枢神经系统功能障碍。
Hum Mol Genet. 2023 Apr 20;32(9):1483-1496. doi: 10.1093/hmg/ddac303.
6
Single-cell dissection of the human brain vasculature.人类大脑血管的单细胞剖析。
Nature. 2022 Mar;603(7903):893-899. doi: 10.1038/s41586-022-04521-7. Epub 2022 Feb 14.
7
Cooperation of cell adhesion and autophagy in the brain: Functional roles in development and neurodegenerative disease.大脑中细胞黏附与自噬的协同作用:在发育和神经退行性疾病中的功能作用
Matrix Biol Plus. 2021 Oct 23;12:100089. doi: 10.1016/j.mbplus.2021.100089. eCollection 2021 Dec.
8
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum.从神经发育障碍到神经退行性疾病:血管连续体
Front Aging Neurosci. 2021 Oct 20;13:749026. doi: 10.3389/fnagi.2021.749026. eCollection 2021.
9
Impaired Cerebrovascular Reactivity in Huntington's Disease.亨廷顿舞蹈症患者的脑血管反应性受损
Front Physiol. 2021 Jul 21;12:663898. doi: 10.3389/fphys.2021.663898. eCollection 2021.
10
Huntingtin silencing delays onset and slows progression of Huntington's disease: a biomarker study.亨廷顿病发病延迟和进展减缓的亨廷顿基因沉默:一项生物标志物研究。
Brain. 2021 Nov 29;144(10):3101-3113. doi: 10.1093/brain/awab190.
年龄相关的神经血管异常和亨廷顿病 YAC128 小鼠模型中微胶质细胞形态的改变。
Neurobiol Dis. 2012 Jan;45(1):438-49. doi: 10.1016/j.nbd.2011.09.003. Epub 2011 Sep 13.
4
Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease.在早期亨廷顿病中,脑血流与脑萎缩之间的复杂关系。
Neuroimage. 2012 Jan 16;59(2):1043-51. doi: 10.1016/j.neuroimage.2011.08.112. Epub 2011 Sep 16.
5
Indexing disease progression at study entry with individuals at-risk for Huntington disease.在研究开始时对亨廷顿病高危个体进行疾病进展的指标检测。
Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(7):751-63. doi: 10.1002/ajmg.b.31232. Epub 2011 Aug 19.
6
Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's disease.临床前期亨廷顿病认知的纵向功能磁共振成像。
Exp Neurol. 2011 Oct;231(2):214-22. doi: 10.1016/j.expneurol.2011.06.011. Epub 2011 Jun 25.
7
Inflow-based vascular-space-occupancy (iVASO) MRI.基于流入的血管空间占据(iVASO)MRI。
Magn Reson Med. 2011 Jul;66(1):40-56. doi: 10.1002/mrm.22775. Epub 2011 Feb 24.
8
Measurement of absolute arterial cerebral blood volume in human brain without using a contrast agent.无需造影剂即可测量人脑的绝对动脉脑血容量。
NMR Biomed. 2011 Dec;24(10):1313-25. doi: 10.1002/nbm.1693. Epub 2011 May 24.
9
Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease.静息态脑血流磁共振灌注成像在临床前期亨廷顿病中的应用。
J Cereb Blood Flow Metab. 2011 Sep;31(9):1908-18. doi: 10.1038/jcbfm.2011.60. Epub 2011 May 11.
10
Physiological origin for the BOLD poststimulus undershoot in human brain: vascular compliance versus oxygen metabolism.人类大脑中 BOLD 刺激后下冲的生理起源:血管顺应性与氧代谢。
J Cereb Blood Flow Metab. 2011 Jul;31(7):1599-611. doi: 10.1038/jcbfm.2011.35. Epub 2011 Apr 6.